Cargando…

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome

The effect of metformin on prolactin concentration seems to be sex-dependent. The aim of this study was to determine whether the androgen status modulates the impact of metformin on plasma prolactin levels in women. This study included two matched groups of prediabetic women with hyperprolactinemia:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krysiak, Robert, Kowalcze, Karolina, Szkróbka, Witold, Okopień, Bogusław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488133/ https://www.ncbi.nlm.nih.gov/pubmed/37685540 http://dx.doi.org/10.3390/jcm12175474

Ejemplares similares

Vitamin D Status Determines the Impact of Metformin on Gonadotropin Levels in Postmenopausal Women
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

The Effect of Metformin on Plasma Prolactin Levels in Young Women with Autoimmune Thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2023)

Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels
por: Krysiak, Robert, et al.
Publicado: (2023)

Sexual Function and Depressive Symptoms in Young Women with Euthyroid Hashimoto’s Thyroiditis Receiving Vitamin D, Selenomethionine and Myo-Inositol: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of rosuvastatin on hypothalamic–pituitary–testicular axis activity in metformin-treated and metformin-naïve men with low testosterone levels: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Cardiometabolic profile of young women with hypoprolactinemia
por: Krysiak, Robert, et al.
Publicado: (2022)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2014)

Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2022)

The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
por: Pruski, Maciej, et al.
Publicado: (2009)

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
por: Mastnak, Lara, et al.
Publicado: (2023)

A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2022)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management
por: Davoudi, Zahra, et al.
Publicado: (2021)

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome
por: Yang, Haiyan, et al.
Publicado: (2021)

Minipuberty in Sons of Women with Low Vitamin D Status during Pregnancy
por: Kowalcze, Karolina, et al.
Publicado: (2023)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Coexistence of primary aldosteronism and Hashimoto’s thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2011)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome
por: Riahinejad, Soheila, et al.
Publicado: (2015)

Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
por: Zeng, Xian-Ling, et al.
Publicado: (2016)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

Lower sexual satisfaction in women with polycystic ovary syndrome and metabolic syndrome
por: Kałużna, Małgorzata, et al.
Publicado: (2021)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Metformin Lowers Serum Cobalamin without Changing Other Markers of Cobalamin Status: A Study on Women with Polycystic Ovary Syndrome
por: Greibe, Eva, et al.
Publicado: (2013)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j542rau25vtv0d90ia6san0thj